We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01134718
Recruitment Status : Completed
First Posted : June 2, 2010
Last Update Posted : April 9, 2013
Information provided by (Responsible Party):
Tibotec Pharmaceuticals, Ireland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2010
  Study Completion Date : August 2010